Xie D - Search Results

1

Profiling and bioinformatics analyses reveal differential circular RNA expression in radioresistant esophageal cancer cells.

Su H, Lin F, Deng X, Shen L, Fang Y, Fei Z, Zhao L, Zhang X, Pan H, Xie D, Jin X, Xie C. Su H, et al. Among authors: xie d, xie c. J Transl Med. 2016 Jul 28;14(1):225. doi: 10.1186/s12967-016-0977-7. J Transl Med. 2016. PMID: 27465405 Free PMC article.

2

Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.

Jin X, Chen Y, Chen H, Fei S, Chen D, Cai X, Liu L, Lin B, Su H, Zhao L, Su M, Pan H, Shen L, Xie D, Xie C. Jin X, et al. Among authors: xie d, xie c. Clin Cancer Res. 2017 Sep 1;23(17):5311-5319. doi: 10.1158/1078-0432.CCR-17-0577. Epub 2017 Jun 12. Clin Cancer Res. 2017. PMID: 28606918

3

Treatment outcome comparisons between exons 19 and 21 EGFR mutations for non-small-cell lung cancer patients with malignant pleural effusion after first-line and second-line tyrosine kinase inhibitors.

Zheng Z, Xie D, Su H, Lin B, Zhao L, Deng X, Chen H, Fei S, Jin X, Xie C. Zheng Z, et al. Among authors: xie d, xie c. Tumour Biol. 2017 Jun;39(6):1010428317706211. doi: 10.1177/1010428317706211. Tumour Biol. 2017. PMID: 28618947 Free article.

4

Adjuvant Therapeutic Modalities Following Three-field Lymph Node Dissection for Stage II/III Esophageal Squamous Cell Carcinoma.

Li L, Zhao L, Lin B, Su H, Su M, Xie D, Jin X, Xie C. Li L, et al. Among authors: xie d, xie c. J Cancer. 2017 Jul 5;8(11):2051-2059. doi: 10.7150/jca.18981. eCollection 2017. J Cancer. 2017. PMID: 28819406 Free PMC article.

5

Efficacy of Second-line Tyrosine Kinase Inhibitors in the Treatment of Metastatic Advanced Non-small-cell Lung Cancer Harboring Exon 19 and 21 EGFR Mutations.

Zheng Z, Jin X, Lin B, Su H, Chen H, Fei S, Zhao L, Deng X, Xie D, Xie C. Zheng Z, et al. Among authors: xie d, xie c. J Cancer. 2017 Feb 15;8(4):597-605. doi: 10.7150/jca.16959. eCollection 2017. J Cancer. 2017. PMID: 28367239 Free PMC article.

6

MicroRNA-488-3p inhibits proliferation and induces apoptosis by targeting ZBTB2 in esophageal squamous cell carcinoma.

Yang Y, Li H, He Z, Xie D, Ni J, Lin X. Yang Y, et al. Among authors: xie d. J Cell Biochem. 2019 Nov;120(11):18702-18713. doi: 10.1002/jcb.29178. Epub 2019 Jun 26. J Cell Biochem. 2019. PMID: 31243806

7

ZNF674-AS1 antagonizes miR-423-3p to induce G0/G1 cell cycle arrest in non-small cell lung cancer cells.

Liu Y, Huang R, Xie D, Lin X, Zheng L. Liu Y, et al. Among authors: xie d. Cell Mol Biol Lett. 2021 Feb 22;26(1):6. doi: 10.1186/s11658-021-00247-y. Cell Mol Biol Lett. 2021. PMID: 33618674 Free PMC article.

8

Clinical features and prognosis of primary tracheal small cell carcinoma: a population-based analysis.

Chen K, Yang Z, Zhang X, Zhao T, Zhang X, Li W, Yu S, Xie D, He Z, Cheng D. Chen K, et al. Among authors: xie d. Transl Cancer Res. 2020 Feb;9(2):882-890. doi: 10.21037/tcr.2019.12.29. Transl Cancer Res. 2020. PMID: 35117433 Free PMC article.

9

Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.

Xie Q, Wen H, Zhang Q, Zhou W, Lin X, Xie D, Liu Y. Xie Q, et al. Among authors: xie d. Biomed Pharmacother. 2017 Jan;85:16-21. doi: 10.1016/j.biopha.2016.11.096. Epub 2016 Dec 5. Biomed Pharmacother. 2017. PMID: 27930981

10

Integrated analysis reveals five potential ceRNA biomarkers in human lung adenocarcinoma.

Liu Y, Xie D, He Z, Zheng L. Liu Y, et al. Among authors: xie d. PeerJ. 2019 Apr 29;7:e6694. doi: 10.7717/peerj.6694. eCollection 2019. PeerJ. 2019. PMID: 31106044 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,541 results

Search Page

Filters